ID   MCC-38
AC   CVCL_A1QL
SY   P2-CL; CL2
DR   cancercelllines; CVCL_A1QL
DR   GEO; GSM4563056
DR   Wikidata; Q102114711
RX   PubMed=33087752;
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=33087752).
CC   Omics: Array-based CGH.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=33087752
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D5S818: 12
ST   D7S820: 8.3,12
ST   D13S317: 13,15,16,17
ST   D16S539: 11,13.1
ST   TH01: 6,7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
RX   PubMed=33087752; DOI=10.1038/s41598-020-74797-0; PMCID=PMC7578805;
RA   Hirsch D., Seyfried S., Staib T., Fiedler D., Sauer C., Ried T.,
RA   Witt S., Rueckert F., Gaiser T.;
RT   "Newly established gastrointestinal cancer cell lines retain the
RT   genomic and immunophenotypic landscape of their parental cancers.";
RL   Sci. Rep. 10:17895-17895(2020).
//